247 related articles for article (PubMed ID: 29096354)
1. Notch signaling pathway dampens tumor-infiltrating CD8
Yu W; Wang Y; Guo P
Biomed Pharmacother; 2018 Jan; 97():535-542. PubMed ID: 29096354
[TBL] [Abstract][Full Text] [Related]
2. Notch signaling pathway suppresses CD8
Li S; Wang Z; Li XJ
Int Immunopharmacol; 2018 Oct; 63():129-136. PubMed ID: 30086535
[TBL] [Abstract][Full Text] [Related]
3. Notch controls generation and function of human effector CD8+ T cells.
Kuijk LM; Verstege MI; Rekers NV; Bruijns SC; Hooijberg E; Roep BO; de Gruijl TD; van Kooyk Y; Unger WW
Blood; 2013 Apr; 121(14):2638-46. PubMed ID: 23380742
[TBL] [Abstract][Full Text] [Related]
4. Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer.
Sierra RA; Thevenot P; Raber PL; Cui Y; Parsons C; Ochoa AC; Trillo-Tinoco J; Del Valle L; Rodriguez PC
Cancer Immunol Res; 2014 Aug; 2(8):800-11. PubMed ID: 24830414
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CD8
Pu Q; Yu L; Liu X; Yan H; Xie Y; Cai X; Wu Y; Du J; Yang Z
Front Immunol; 2024; 15():1375864. PubMed ID: 38650927
[TBL] [Abstract][Full Text] [Related]
6. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
7. Notch Signaling Regulates Circulating T Helper 22 Cells in Patients with Chronic Hepatitis C.
Jiang BC; Liu X; Liu XH; Li ZS; Zhu GZ
Viral Immunol; 2017 Sep; 30(7):522-532. PubMed ID: 28410452
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
9. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
[TBL] [Abstract][Full Text] [Related]
11. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
12. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
[TBL] [Abstract][Full Text] [Related]
13. Notch Signaling Modulates the Balance of Regulatory T Cells and T Helper 17 Cells in Patients with Chronic Hepatitis C.
Qin L; Zhou YC; Wu HJ; Zhuo Y; Wang YP; Si CY; Qin YM
DNA Cell Biol; 2017 Apr; 36(4):311-320. PubMed ID: 28157396
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Notch in activation and effector functions of γδ T cells.
Gogoi D; Dar AA; Chiplunkar SV
J Immunol; 2014 Mar; 192(5):2054-62. PubMed ID: 24489102
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 Dampens CD8
Yang L; Shao X; Jia S; Zhang Q; Jin Z
Front Immunol; 2019; 10():1032. PubMed ID: 31134088
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.
Thounaojam MC; Dudimah DF; Pellom ST; Uzhachenko RV; Carbone DP; Dikov MM; Shanker A
Oncotarget; 2015 Oct; 6(32):32439-55. PubMed ID: 26431276
[TBL] [Abstract][Full Text] [Related]
18. Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.
Xu B; Yuan L; Gao Q; Yuan P; Zhao P; Yuan H; Fan H; Li T; Qin P; Han L; Fang W; Suo Z
Oncotarget; 2015 Aug; 6(24):20592-603. PubMed ID: 26008981
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
Zhu S; Lin J; Qiao G; Xu Y; Zou H
Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
[TBL] [Abstract][Full Text] [Related]
20. Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.
Fiorini E; Merck E; Wilson A; Ferrero I; Jiang W; Koch U; Auderset F; Laurenti E; Tacchini-Cottier F; Pierres M; Radtke F; Luther SA; Macdonald HR
J Immunol; 2009 Dec; 183(11):7212-22. PubMed ID: 19915064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]